These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 3058042)
61. A randomized trial of adjuvant endocrine therapy, chemotherapy, and chemoendocrine therapy for operable breast cancer stratified by estrogen receptors. Nomura Y; Tashiro H; Hisamatsu K; Shinozuka K Cancer; 1988 Jun; 61(11):2168-75. PubMed ID: 3130175 [TBL] [Abstract][Full Text] [Related]
63. [The role of adjuvant endocrine therapy in the management of operable breast cancer]. Miura S; Yoshida M; Murai H Gan To Kagaku Ryoho; 1988 Dec; 15(12):3203-13. PubMed ID: 3058042 [TBL] [Abstract][Full Text] [Related]
64. [Systemic adjuvant chemo-endocrine therapy after breast conservation treatment for breast cancer]. Miura S; Murai H; Yoshida M Rinsho Byori; 1993 Oct; 41(10):1125-32. PubMed ID: 8254958 [TBL] [Abstract][Full Text] [Related]
65. Optimal systemic therapy for premenopausal women with hormone receptor-positive breast cancer. Jankowitz RC; McGuire KP; Davidson NE Breast; 2013 Aug; 22 Suppl 2():S165-70. PubMed ID: 24074781 [TBL] [Abstract][Full Text] [Related]
66. Is there a role for perioperative adjuvant cytotoxic therapy in the treatment of early breast cancer? Houghton J; Baum M; Nissen-Meyer R; Riley D; Hern RA Recent Results Cancer Res; 1989; 115():54-61. PubMed ID: 2696041 [No Abstract] [Full Text] [Related]
67. Adjuvant therapy for breast cancer. Kaufmann M Curr Opin Oncol; 1991 Dec; 3(6):1019-23. PubMed ID: 1843102 [TBL] [Abstract][Full Text] [Related]